Anticoagulation Reversal Agent | ANDEXXA | For HCPs
网页ANDEXXA ® (coagulation factor Xa [recombinant], inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due …
Andexxa Uses, Side Effects & Warnings - Drugs.com
网页2023年8月16日 · Andexxa is used to reverse the effects of anticoagulant medication, which may increase your risk of a blood clot, heart attack, stroke, or death. Watch for symptoms such as chest pain, sudden numbness or weakness, problems with vision or speech, and swelling or redness in an arm or leg.
ANDEXXA | FDA - U.S. Food and Drug Administration
网页2022年5月26日 · ANDEXXA. STN: BLA 125586 Proper Name: coagulation factor Xa (recombinant), inactivated-zhzo Trade Name: ANDEXXA Manufacturer: Alexion Pharmaceuticals, Inc. Indication: Indicated for patients ...
Andexanet alfa - Wikipedia
网页Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation is needed due to uncontrolled bleeding. [8]
Dosing and Administration | ANDEXXA | For HCPs
网页ANDEXXA ® (coagulation factor Xa [recombinant], inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due …
Andexxa - AstraZeneca US
网页Reversing FXa inhibitor therapy exposes patients to the thrombotic risk of their underlying disease. To reduce the risk of thrombosis, resume anticoagulant therapy as soon as medically appropriate following treatment with ANDEXXA.</paragraph> </text> <effectiveTime value="20240328"/> </section> </component> </section>.
网页ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal...
Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral ...
网页On May 03, 2018, the FDA approved andexanet alfa (Andexxa ®), the first and only specific antidote for anticoagulation reversal in patients treated with rivaroxaban or apixaban. 7 INDICATION Andexanet alfa is indicated for anticoagulation reversal in life-threatening or uncontrolled bleeding in patients treated with rivaroxaban or apixaban.
Andexxa (andexanet alfa): Drug Basics and Frequently Asked ... - GoodRx
网页2022年4月10日 · Andexxa (andexanet alfa) is an injectable medication used to treat life-threatening or uncontrolled bleeding in people taking anticoagulants (blood thinners) called Xarelto (rivaroxaban) or Eliquis (apixaban).
网页ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.